24.06.2015 • News

Americans Blame Drugmakers for High Prices

© Nikolai Sorokin - Fotolia.com
© Nikolai Sorokin - Fotolia.com

Americans are far more likely to blame pharmaceutical companies for high prescription medication costs than their health insurers, a recent poll has found. Of the 1,200 adults interviewed by the Kaiser Family Foundation’s researchers for the June Kaiser Health Tracking Poll, around three-quarters said the cost of prescription drug costs was unreasonable, but only10% of those responding blamed the high prices on co-pays demanded by their insurance company.

A similar majority said drug profits were a major factor in prescription prices, and 87% approved of enabling the Medicare program to negotiate prices with producers.

At the same time, over 70% of the poll’s respondents said they thought insurers should always pay for an expensive drug recommended by a doctor when no lower-cost alternative exists.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.